Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade

Background: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signali...

Full description

Bibliographic Details
Main Authors: Aneta Piwowarczyk-Nowak, Artur Pałasz, Aleksandra Suszka-Świtek, Iwona Błaszczyk, Katarzyna Bogus, Barbara Łasut-Szyszka, Marek Krzystanek, John J. Worthington
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/5/631
_version_ 1797496836012900352
author Aneta Piwowarczyk-Nowak
Artur Pałasz
Aleksandra Suszka-Świtek
Iwona Błaszczyk
Katarzyna Bogus
Barbara Łasut-Szyszka
Marek Krzystanek
John J. Worthington
author_facet Aneta Piwowarczyk-Nowak
Artur Pałasz
Aleksandra Suszka-Świtek
Iwona Błaszczyk
Katarzyna Bogus
Barbara Łasut-Szyszka
Marek Krzystanek
John J. Worthington
author_sort Aneta Piwowarczyk-Nowak
collection DOAJ
description Background: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signaling, especially in the context of adult neurogenesis and the expression of noncanonical stress-related neuropeptides such as neuromedin U (NMU). The present work therefore focused on immunoexpression of neuromedin U receptor 2 (NMUR2) and doublecortin (DCX) in the rat hippocampus after acute treatment with escitalopram and in combination with selective neuropeptide S receptor (NPSR) blockade. Methods: Studies were carried out on adult, male Sprague-Dawley rats that were divided into five groups: animals injected with saline (control) and experimental individuals treated with escitalopram (at single dose 10 mg/kg daily), escitalopram + SHA-68, a selective NPSR antagonist (at single dose 40 mg/kg), SHA-68 alone, and corresponding vehicle control. All animals were sacrificed under halothane anaesthesia. The whole hippocampi were quickly excised, fixed, and finally sliced for general qualitative immunohistochemical assessment of the NPSR and NMUR2 expression. The number of immature neurons was enumerated using immunofluorescent detection of doublecortin (DCX) expression within the subgranular zone (SGZ). Results: Acute escitalopram administration affects the number of DCX and NMUR2-expressing cells in the adult rat hippocampus. A decreased number of DCX-expressing neuroblasts after treatment with escitalopram was augmented by SHA-68 coadministration. Conclusions: Early pharmacological effects of escitalopram may be at least partly connected with local NPSR-related alterations of neuroblast maturation in the rat hippocampus. Escitalopram may affect neuropeptide and DCX-expression starting even from the first dose. Adult neurogenesis may be regulated via paracrine neuropeptide S and NMU-related signaling.
first_indexed 2024-03-10T03:09:13Z
format Article
id doaj.art-221881a91500498097a209f70a2eaa3c
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T03:09:13Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-221881a91500498097a209f70a2eaa3c2023-11-23T12:35:43ZengMDPI AGPharmaceuticals1424-82472022-05-0115563110.3390/ph15050631Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor BlockadeAneta Piwowarczyk-Nowak0Artur Pałasz1Aleksandra Suszka-Świtek2Iwona Błaszczyk3Katarzyna Bogus4Barbara Łasut-Szyszka5Marek Krzystanek6John J. Worthington7Department of Anatomy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandCenter for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandClinic of Psychiatric Rehabilitation, Department of Psychiatry and Psychotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Ziolowa 45/47, 40-635 Katowice, PolandDivision of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UKBackground: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signaling, especially in the context of adult neurogenesis and the expression of noncanonical stress-related neuropeptides such as neuromedin U (NMU). The present work therefore focused on immunoexpression of neuromedin U receptor 2 (NMUR2) and doublecortin (DCX) in the rat hippocampus after acute treatment with escitalopram and in combination with selective neuropeptide S receptor (NPSR) blockade. Methods: Studies were carried out on adult, male Sprague-Dawley rats that were divided into five groups: animals injected with saline (control) and experimental individuals treated with escitalopram (at single dose 10 mg/kg daily), escitalopram + SHA-68, a selective NPSR antagonist (at single dose 40 mg/kg), SHA-68 alone, and corresponding vehicle control. All animals were sacrificed under halothane anaesthesia. The whole hippocampi were quickly excised, fixed, and finally sliced for general qualitative immunohistochemical assessment of the NPSR and NMUR2 expression. The number of immature neurons was enumerated using immunofluorescent detection of doublecortin (DCX) expression within the subgranular zone (SGZ). Results: Acute escitalopram administration affects the number of DCX and NMUR2-expressing cells in the adult rat hippocampus. A decreased number of DCX-expressing neuroblasts after treatment with escitalopram was augmented by SHA-68 coadministration. Conclusions: Early pharmacological effects of escitalopram may be at least partly connected with local NPSR-related alterations of neuroblast maturation in the rat hippocampus. Escitalopram may affect neuropeptide and DCX-expression starting even from the first dose. Adult neurogenesis may be regulated via paracrine neuropeptide S and NMU-related signaling.https://www.mdpi.com/1424-8247/15/5/631escitalopramneuropeptide Shippocampusneuromedin UNPSRNMUR2
spellingShingle Aneta Piwowarczyk-Nowak
Artur Pałasz
Aleksandra Suszka-Świtek
Iwona Błaszczyk
Katarzyna Bogus
Barbara Łasut-Szyszka
Marek Krzystanek
John J. Worthington
Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
Pharmaceuticals
escitalopram
neuropeptide S
hippocampus
neuromedin U
NPSR
NMUR2
title Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
title_full Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
title_fullStr Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
title_full_unstemmed Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
title_short Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
title_sort effect of escitalopram on the number of dcx positive cells and nmur2 receptor expression in the rat hippocampus under the condition of npsr receptor blockade
topic escitalopram
neuropeptide S
hippocampus
neuromedin U
NPSR
NMUR2
url https://www.mdpi.com/1424-8247/15/5/631
work_keys_str_mv AT anetapiwowarczyknowak effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT arturpałasz effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT aleksandrasuszkaswitek effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT iwonabłaszczyk effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT katarzynabogus effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT barbarałasutszyszka effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT marekkrzystanek effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade
AT johnjworthington effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade